Please Wait...

Books and Book Sections

Books and Book Sections

2014

Miller CG, Krasnow J, Schwartz LH. Medical Imaging in Clinical Trials. Published by Springer-Verlag London Ltd. 2014.

Hide All Authored Chapters

  • Medical Imaging Modalities
    • H Ahmad, HJ Yu, CG Miller
  • The Metrics and New Imaging Marker Qualification in Medical Imaging Modalities
    • CG Miller
  • Radiation Risks and Dosimetry Assessment
    • D Pearson
  • Imaging Review Charters and Operational Considerations
    • AM Perrone, JA Villetard
  • Defining the Radiological Blinded Read and Adjudication
    • CG Miller
  • Medical Imaging in Drug Development
    • J Krasnow
  • Evaluating and Working with an Imaging Core Laboratory
    • ES Forsthoffer, J Krasnow
  • Monitoring Responses to Therapy in Oncology
    • B Zhao, LH Schwartz
  • Cardiac Imaging in Clinical Trials
    • GP Heyrich, J Krasnow
  • Neuroimaging in Clinical Trials
    • SN Niogi, AJ Tsiouris
  • Imaging in Musculoskeletal, Metabolic, Endocrinological, and Pediatric Clinical Trials
    • CG Miller, HJ Yu, Cv Kuijk
  • Body Composition
    • JA Shepherd
  • Optical Coherence Tomography as a Biomarker in Clinical Trials for Ophthalmology and Neurology
    • RC Sergott
  • Nuclear Medicine: An Overview of Imaging Techniques, Clinical Applications and Trials
    • A Mehndiratta, P Anandaraj
  • Contrast Agents in Radiology
    • Hv Tengg-Kobligk, A Mehndiratta
  • Pharmaceutical Industry Perspective Regarding Imaging Techniques
    • J Krasnow

2008

Reid D, Miller CG. Clinical Trials in Rheumatoid Arthritis and Osteoarthritis. Published by Springer-Verlag London Ltd. 2008.

Hide All Authored Chapters

  • Introduction
    • DM Reid
  • Historical and Current Perspectives on Management of Osteoarthritis and Rheumatoid Arthritis
    • S Dubey, AO Adebajo
  • Development of Biological Therapies for Inflammatory Arthritis
    • N Basu
  • Study Design and End Points for Rheumatoid Arthritis Trials
    • P Geusens, CG Miller
  • Study Design and End Points in Ankylosing Spondylitis Clinical Trials
    • Dvd Heijde
  • Trial Design and Outcomes in Osteoarthritis
    • N Arden
  • Ethical Considerations
    • D Pearson
  • Organization of the Clinical Trial by the Sponsor
    • CG Miller
  • Organization of the Trial attheInvestigator Site
    • J Shotton, DM Reid
  • Role of the Imaging Core Laboratory in Rheumatoid Arthritis and Osteoarthritis Clinical Trials
    • MD Endres, AM Baratelle
  • Biochemical Markers of Rheumatoid Arthritis and Osteoarthritis: Clinical Utility and Practical Considerations
    • MR Ehlers, ET Leary
  • Data Analysis and Presentation: Writing a Paper for Publication
    • D Pearson
  • Radiographic Imaging End Points in Rheumatoid Arthritis Trials
    • AM Baratelle, Dvd Heijde
  • Radiography in Clinical Trials Investigating Osteoarthritis
    • Cv Kuijk
  • Use of Quantitative Magnetic Resonance Imaging in the Cross-Sectional and Longitudinal Evaluation of Structural Changes in Knee Osteoarthritis Patients
    • JP Raynauld
  • Biochemical Markers as Surrogate End Points of Joint Disease
    • LS Lohmander, DR Eyre
  • Role of Genetics and Genomics in Clinical Trials in Osteoarthritis and Rheumatoid Arthritis
    • SH Ralston
  • Cost-Effectiveness of New Biologics for Rheumatoid Arthritis and Osteoarthritis
    • YB Vergel, D Torgerson

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @endpts: #FDA revises draft guidance on #raredisease drug R&D https://t.co/KaNVw54MDE by @ZacharyBrennan via @RAPSorg
Bioclinica (8 hours ago)
RT @PrimeVigilance: News and Press Release - Source @EMA_News now available monthly meeting highlights from #Pharmacovigilance #RiskAssessm…
Bioclinica (8 hours ago)
RT @FDA_Drug_Info: New #FDA Draft Guidance for Industry on Rare Diseases – Common Issues in Drug Development: https://t.co/yxaGyMB7hY. http…
Bioclinica (8 hours ago)
Looking to exercise DDDM in clinical trials? Get tips on obtaining, distilling and presenting data in our new white… https://t.co/NkGrS9JnG8
Bioclinica (10 hours ago)
Is your clinical study supply chain management solution increasing the risk of stock out? Ehsan Ramezani gives pers… https://t.co/YCfP3wCvK6
Bioclinica (Yesterday)
Bioclinica's Kate Adamczuk is presenting at #HAI2019 today! Details on this and other scientific findings at HAI… https://t.co/wDQr6ldfcS
Bioclinica (Yesterday)

Latest Blogs:

Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner